Finished
Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and Tetraplegia
NCT06939634 · Wandercraft · Updated 23 April 2025
- What is being tested
- Hands-free exoskeleton
- For
- Spinal Cord Injury; Tetraplegia/Tetraparesis; Paraplegia, Complete; Paraplegia, Incomplete; Guillain Barré Syndrome
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 35 people. The full rules are on the registry page.
- Where
- France (3 sites)
- When
- Starts or started 1 June 2024, ends 1 Sept 2024. Registered 23 April 2025.
- Results
- None posted yet.
In the researchers' words
The objective of this clinical trial is to determine whether the Atalante X exoskeleton can be safely utilized by patients with tetraplegia and high paraplegia (at or above T4).
Sites
- Fondation HopaleBerck, France, France
- CMPR de PionsatPionsat, France, France
- Hôpital La MusseSaint-Sébastien-de-Morsent, France, France